SLDB · NASDAQ
Solid Biosciences (SLDB) Stock Price & Fundamentals
Solid Biosciences (SLDB) closed at $538.61 on Oct 9, 2026, up 0.76% from the previous close of $534.54.
Share price, past year
1Y +16.70%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $538.61 |
| Sep 30, 2026 | $535.18 |
| Aug 31, 2026 | $564.16 |
| Jul 31, 2026 | $522.48 |
| Jun 30, 2026 | $508.14 |
| May 29, 2026 | $549.78 |
| Apr 30, 2026 | $525.98 |
| Mar 31, 2026 | $542.06 |
| Feb 27, 2026 | $529.62 |
| Jan 30, 2026 | $513.22 |
| Dec 31, 2025 | $505.84 |
| Nov 28, 2025 | $483.14 |
| Oct 31, 2025 | $466.91 |
Key statistics
- Market cap
- $56.62B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.88
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 105.1M
- Dividend yield
- —
- 52-week range
- $458.48 – $569.39
Solid Biosciences's market cap is $56.62B, based on a share price of $538.61 and 105.1M shares outstanding as of Jun 30, 2026.
Financials
Solid Biosciences reported revenue of $8.09M for fiscal 2022, down 40.57% from fiscal 2021.
Solid Biosciences reported a net loss of $117.22M in fiscal 2019.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2022ended Dec 31, 2022 | $8.09M | −40.6% | — | — | −$10.10 | −$100.99M |
| FY2021ended Dec 31, 2021 | $13.62M | — | — | — | −$10.14 | −$79.05M |
| FY2020ended Dec 31, 2020 | $0.00 | — | — | — | −$380.60 | −$57.50M |
| FY2019ended Dec 31, 2019 | $0.00 | — | −$117.22M | — | −$43.43 | −$97.10M |
| FY2018ended Dec 31, 2018 | $0.00 | — | −$74.80M | — | −$33.58 | −$77.97M |
| FY2017ended Dec 31, 2017 | $0.00 | — | −$52.12M | — | −$42.99 | −$45.50M |
| FY2016ended Dec 31, 2016 | $0.00 | — | −$21.54M | — | −$151.34 | −$20.51M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2020ended Dec 31, 2020 | $0.00 | — | — |
| Q3 FY2020ended Sep 30, 2020 | $0.00 | −$21.25M | — |
| Q2 FY2020ended Jun 30, 2020 | $0.00 | −$18.99M | — |
| Q1 FY2020ended Mar 31, 2020 | $0.00 | −$26.69M | — |
| Q4 FY2019ended Dec 31, 2019 | $0.00 | −$31.86M | — |
| Q3 FY2019ended Sep 30, 2019 | $0.00 | −$29.26M | — |
| Q2 FY2019ended Jun 30, 2019 | $0.00 | — | — |
| Q1 FY2019ended Mar 31, 2019 | $0.00 | — | — |
Company profile
- Name
- Solid Biosciences Inc.
- Ticker
- SLDB
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 500 Rutherford Avenue, 3rd Floor, Charlestown, MA 02129
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001707502
Recent SEC filings
- Aug 6, 2026
- Aug 6, 2026
- Jun 10, 2026
- May 12, 2026
- Apr 10, 2026
- Mar 19, 2026
- Mar 12, 2026
- Mar 6, 2026
Frequently asked questions
What is Solid Biosciences's stock price?
Solid Biosciences (SLDB) closed at $538.61 on Oct 9, 2026, up 0.76% from the previous close of $534.54.
What is Solid Biosciences's market cap?
Solid Biosciences's market cap is $56.62B, based on a share price of $538.61 and 105.1M shares outstanding as of Jun 30, 2026.
How much revenue does Solid Biosciences make?
Solid Biosciences reported revenue of $8.09M for fiscal 2022, down 40.57% from fiscal 2021.
Sources and methodology
Fundamentals come from Solid Biosciences Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures